In vivo delivery of a DNA-encoded monoclonal antibody protects non-human primates against Zika virus RN Esquivel, A Patel, SB Kudchodkar, DH Park, K Stettler, M Beltramello, ... Molecular Therapy 27 (5), 974-985, 2019 | 49 | 2019 |
Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri MC McCloskey, S Shaheen, L Rabago, MA Hulverson, R Choi, LK Barrett, ... Scientific Reports 9 (1), 13567, 2019 | 11 | 2019 |
Multicenter prospective study of biomarkers for diagnosis of invasive candidiasis in children and adolescents BT Fisher, CLK Boge, R Xiao, S Shuster, D Chin-Quee, J Allen IV, ... Clinical Infectious Diseases 75 (2), 248-259, 2022 | 10 | 2022 |
Structures of glyceraldehyde 3‐phosphate dehydrogenase in Neisseria gonorrhoeae and Chlamydia trachomatis KF Barrett, DM Dranow, IQ Phan, SA Michaels, S Shaheen, ED Navaluna, ... Protein Science 29 (3), 768-778, 2020 | 10 | 2020 |
The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp E Fernández Álvaro, P Voong Vinh, C de Cozar, DR Willé, B Urones, ... Elife 11, e69798, 2022 | 8* | 2022 |
In Vitro Activity of APX2041, a New Gwt1 Inhibitor, and In Vivo Efficacy of the Prodrug APX2104 against Aspergillus fumigatus SK Shaheen, PR Juvvadi, J Allen IV, EK Shwab, DC Cole, YG Asfaw, ... Antimicrobial Agents and Chemotherapy 65 (10), 10.1128/aac. 00682-21, 2021 | 5 | 2021 |
The protein kinase A-dependent phosphoproteome of the human pathogen Aspergillus fumigatus reveals diverse virulence-associated kinase targets EK Shwab, PR Juvvadi, G Waitt, S Shaheen, J Allen IV, EJ Soderblom, ... Mbio 11 (6), 10.1128/mbio. 02880-20, 2020 | 4 | 2020 |
Solution structure for an Encephalitozoon cuniculi adrenodoxin‐like protein in the oxidized state S Shaheen, KF Barrett, S Subramanian, SLM Arnold, JA Laureanti, ... Protein Science 29 (3), 809-817, 2020 | 4 | 2020 |
Polyomavirus wakes up and chooses neurovirulence AB Butic, SA Spencer, SK Shaheen, AE Lukacher Viruses 15 (10), 2112, 2023 | 3 | 2023 |
Repurposing tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively-drug resistant (XDR) Shigella spp. EF Alvaro, PV Vinh, C de Cozar, B Urones, A Cortés, A Price, ... | 2 | 2021 |
Protein Kinase A Regulates Autophagy-Associated Proteins Impacting Growth and Virulence of Aspergillus fumigatus EK Shwab, PR Juvvadi, SK Shaheen, J Allen IV, G Waitt, EJ Soderblom, ... Journal of Fungi 8 (4), 354, 2022 | 1 | 2022 |
Erratum: Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents (Clin Infect Dis BT Fisher, CLK Boge, R Xiao, S Shuster, D Chin-Quee, J Allen, ... Clinical Infectious Diseases 76 (5), 972, 2023 | | 2023 |
Polyomavirus wakes up and chooses neurovirulence (preprint) AB Butic, SA Spencer, SK Shaheen, AE Lukacher | | 2023 |
The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp. C de Cozar, DR Willé, B Urones, A Cortés, A Price, N Tran Do Hoang, ... Elife 11, e69798-e69798, 2022 | | 2022 |
Correction: The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp EF Álvaro, PV Vinh, C de Cozar, DR Willé, B Urones, A Cortés, A Price, ... Elife 11, 2022 | | 2022 |
1614. Gwt1 Inhibitor, APX2104, Protects Against Invasive Aspergillosis in Neutropenic Mouse Model S Shaheen, J Allen IV, DC Cole, Y Asfaw, P Juvvadi, EK Shwab, ... Open Forum Infectious Diseases 7 (Suppl 1), S800, 2020 | | 2020 |
Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri (vol 9, 13567, 2019) MC McCloskey, S Shaheen, L Rabago, MA Hulverson, R Choi, LK Barrett, ... SCIENTIFIC REPORTS 10 (1), 2020 | | 2020 |
Author Correction: Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri MC McCloskey, S Shaheen, L Rabago, MA Hulverson, R Choi, LK Barrett, ... Scientific Reports 10, 2020 | | 2020 |
Identification and characterization of novel therapeutics for the treatment of cryptosporidiosis and shigellosis S Arnold, R Choi, M Hulverson, G Whitman, L Rabago, S Shaheen, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
Development of novel in vitro and in vivo models to evaluate antibiotic efficacy against shigellosis S Arnold, M McCloskey, S Shaheen, M Hulverson, R Choi The FASEB Journal 32, 570.4-570.4, 2018 | | 2018 |